F. Binder-foucard, A. Belot, P. Delafosse, L. Remontet, A. Woronoff et al., Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 -Tumeurs solides

S. Bülow, N. T. Faurschou, and C. Bülow, The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register, Int J Colorectal Dis, vol.11, pp.88-91, 1996.

H. Hampel, W. L. Frankel, and E. Martin, Feasibility of screening for Lynch syndrome among patients with colorectal cancer, J Clin Oncol, vol.26, pp.5783-5788, 2008.

L. A. Brosens, G. J. Offerhaus, and F. M. Giardiello, Hereditary colorectal cancer: Genetics and screening, Surg Clin North Am, vol.95, pp.1067-1080, 2015.

A. Warthin, Heredity with reference to carcinoma: As shown by the study of the cases examined in the pathological laboratory of the university of michigan, Arch Intern Med, vol.XII, issue.5, pp.546-55, 1913.

H. T. Lynch, M. W. Shaw, C. W. Magnuson, A. L. Larsen, and A. J. Krush, Hereditary factors in cancer: Study of two large midwestern kindreds, Arch Intern Med, vol.117, issue.2, pp.206-218, 1966.

H. T. Lynch, P. M. Lynch, S. J. Lanspa, C. L. Snyder, J. F. Lynch et al., Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications, Clin Genet, vol.76, issue.1, pp.1-18, 2009.

M. J. Ligtenberg, R. P. Kuiper, and T. L. Chan, Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ´ exons of TACSTD1, Nat Genet, vol.41, pp.112-129, 2009.

H. T. Lynch, A. De-la-chapelle, G. Tranø, H. H. Wasmuth, W. Sjursen et al., Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study, Colorectal Dis Off J Assoc Coloproctology G B Irel, vol.348, issue.10, pp.456-61, 2003.

M. Mvundura, S. D. Grosse, H. Hampel, and G. E. Palomaki, The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer, Genet Med, vol.12, issue.2, pp.93-104, 2010.

S. D. Grosse, G. E. Palomaki, M. Mvundura, and H. Hampel, The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates, Genet Med, vol.17, issue.6, pp.510-511, 2015.

H. J. Järvinen, M. Aarnio, H. Mustonen, K. Aktan-collan, L. A. Aaltonen et al., Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer, Gastroenterology, vol.118, issue.5, pp.829-863, 2000.

H. F. Vasen, M. Abdirahman, and R. Brohet, One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome, Gastroenterology, vol.138, pp.2300-2306, 2010.

H. F. Vasen, J. T. Wijnen, F. H. Menko, J. H. Kleibeuker, B. G. Taal et al., Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis, Gastroenterology, vol.110, issue.4, pp.1020-1027, 1996.

D. L. Edelstein, J. Axilbund, M. Baxter, L. M. Hylind, K. Romans et al., Rapid development of colorectal neoplasia in patients with Lynch syndrome, Clin Gastroenterol Hepatol, vol.9, pp.340-343, 2011.

E. Stoffel, B. Mukherjee, V. M. Raymond, N. Tayob, F. Kastrinos et al., Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome, Gastroenterology, vol.137, issue.5, pp.1621-1628, 2009.

V. Bonadona, B. Bonaïti, S. Olschwang, S. Grandjouan, L. Huiart et al., Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome, Journal of the American Medical Association, vol.305, issue.22, pp.2304-2314, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00780536

M. J. Kempers, R. P. Kuiper, and C. W. Ockeloen, Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study, Lancet Oncol, vol.12, pp.49-55, 2011.

P. Moller, T. Seppälä, and I. Bernstein, Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database, Gut, vol.66, issue.9, pp.1657-1664, 2017.

J. P. Mecklin, M. Aarnio, and E. Läärä, Development of Colorectal Tumors in Colonoscopic Surveillance in Lynch Syndrome, Gastroenterology, vol.133, pp.1093-1098, 2007.

A. Liljegren, G. Barker, F. Elliott, L. Bertario, M. L. Bisgaard et al., Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2, J Clin Oncol, vol.26, pp.3434-3439, 2008.

A. Botma, F. M. Nagengast, M. G. Braem, J. C. Hendriks, J. H. Kleibeuker et al., Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study, J Clin Oncol, vol.28, pp.4346-4353, 2010.

V. Rodrigues, R. Claro, I. Lage, and P. , Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study, Int J Colorectal Dis, vol.33, p.695, 2018.

R. M. Winkels, A. Botma, F. J. Van-duijnhoven, F. M. Nagengast, and J. H. Kleibeuker,

H. F. Vasen, Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome, Gastroenterology, vol.142, pp.241-248, 2012.

J. L. Vleugels, Endoscopic detection rate of sessile serrated lesions in Lynch syndrome patients is comparable with an age-and gender-matched control population: case-control study with expert pathology review, Gastrointestinal Endoscopy, vol.87, issue.5, pp.1289-1296, 2018.

L. Moreira, F. Balaguer, and N. Lindor, Identification of Lynch syndrome among patients with colorectal cancer, Journal of the American Medical Association, vol.308, issue.15, pp.1555-1565, 2012.

G. Perrod, E. Samaha, and G. Rahmi, Impact of an optimized colonoscopic screening program for patients with Lynch syndrome: 6-year results of a specialized French network, Therapeutic Advances in Gastroenterology, vol.11, p.1756284818775058, 2018.